Patents Assigned to University of Tennessee Research
  • Patent number: 12157896
    Abstract: The invention relates to genes which may be utilized to induce resistance to soybean cyst nematode (SCN). More specifically the present disclosure provides genes that, when inactivated or overexpressed in a plant, particularly, a soybean plant, can confer upon the plant resistance to SCN. Methods of using these genes to obtain plants, particularly, soybean plants, that are resistant to SCN are also provided.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: December 3, 2024
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Tarek Abdelfattah Hewezi, Aditi Rambani, Vincent R. Pantalone, J. Hollis Rice
  • Patent number: 12157765
    Abstract: Provided herein are modified immunoglobulins comprising an amyloid reactive peptide joined to an antibody, as well as humanized antibodies that bind to human amyloid fibrils and antibody-peptide fusion proteins. Also provided herein are methods of treating amyloid-based diseases by administering a modified immunoglobulin, humanized antibody, or antibody-peptide fusion protein.
    Type: Grant
    Filed: May 9, 2024
    Date of Patent: December 3, 2024
    Assignees: Attralus, Inc., UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Jonathan S. Wall, James S. Foster, Spencer Guthrie
  • Patent number: 12157845
    Abstract: A self-healing adhesive composition comprising a homogeneous mixture of: (i) a self-healing polymer containing hydrogen bonding groups or long-chain alkyl groups, wherein said hydrogen bonding groups comprise hydrogen bond donating groups and hydrogen bond accepting groups, and wherein said long-chain alkyl groups contain at least four carbon atoms; and (ii) an extrudable adhesive polymer base having a curable property and no self-healable property; wherein component (i) is present in the self-healing adhesive composition in an amount of at least 10 wt % and up to 70 wt % of the total of components (i) and (ii). Also described herein is a method of sealing a space (e.g., crack, gap, or pores) in a substrate material by at least partially filling the space with the self-healing adhesive composition described above and permitting the self-healing adhesive composition to harden over time without applying an external stimulus to induce hardening.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: December 3, 2024
    Assignees: UT-Battelle, LLC, University of Tennessee Research Foundation
    Inventors: Diana Hun, Pengfei Cao, Tomonori Saito, Zhen Zhang, Bingrui Li, Natasha Ghezawi
  • Publication number: 20240392483
    Abstract: An improved method of preparing a carbon fiber-reinforced thermoplastic nonwoven web using recycled carbon fibers employs resonant acoustic mixing to combine the recycled carbon fibers with the thermoplastic fibers, followed by carding of the fiber mixture to form the carbon-fiber reinforced nonwoven web. The method provides a low-cost way to make carbon-fiber reinforced nonwoven webs that have sufficient mechanical properties to enable widespread use in the automotive industry and other high-volume industries.
    Type: Application
    Filed: May 1, 2024
    Publication date: November 28, 2024
    Applicant: University of Tennessee Research Foundation
    Inventors: Vinit Dilipbhai Chaudhary, Uday Kumar Vaidya, Pritesh Sudhakar Yeole
  • Patent number: 12139529
    Abstract: Provided herein are antibody-peptide fusion proteins comprising an amyloid-reactive peptide linked to an antibody. Also provided herein are methods of treating amyloid-based diseases by administering an antibody-peptide fusion protein.
    Type: Grant
    Filed: April 11, 2023
    Date of Patent: November 12, 2024
    Assignees: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, ATTRALUS, INC.
    Inventors: Jonathan S. Wall, James S. Foster, Spencer Guthrie, Jaume Pons, Michael L. Klein
  • Patent number: 12138303
    Abstract: A multivalent immunogenic composition is provided, including one or more recombinant proteins selected from the group consisting of a recombinant attenuated Staphylococcus pseudintermedius Protein A (SEQ ID NO:2), a recombinant attenuated Staphylococcus pseudintermedius Leukotoxin S (SEQ ID NO:4), a recombinant attenuated Staphylococcus pseudintermedius Nucleotidase adenosine synthase protein (AdsA) (SEQ ID NO:6), a recombinant attenuated Staphylococcus pseudintermedius coagulase (SEQ ID NO:8), a recombinant attenuated Staphylococcus pseudintermedius Leukotoxin F (SEQ ID NO:10), and a recombinant attenuated Staphylococcus pseudintermedius exotoxin 15 (SEQ ID NO:12). Synthetic genes expressing the attenuated recombinant proteins and optimized for expression in E. coli are provided. Vaccines and therapeutic compositions comprising the one or more recombinant proteins are provided.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: November 12, 2024
    Assignee: University of Tennessee Research Foundation
    Inventors: Stephen A. Kania, David Bemis, Mohamed A. Abouelkhair
  • Patent number: 12128026
    Abstract: This invention provides novel indole, indazole, benzimidazole, benzotriazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (SARD) compounds, pharmaceutical compositions and uses thereof in treating hyperproliferations of the prostate including pre-malignancies and benign prostatic hyperplasia, prostate cancer, advanced prostate cancer, castration resistant prostate cancer, other AR-expressing cancers, androgenic alopecia or other hyper androgenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels (through degradation) and/or activity (through inhibition) of any androgen receptor including androgen receptor-full length (AR-FL) including pathogenic and/or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: October 29, 2024
    Assignees: University of Tennessee Research Foundation, Oncternal Therapeutics, Inc.
    Inventors: Ramesh Narayanan, Duane D. Miller, Thamarai Ponnusamy, Dong-Jin Hwang, Yali He, Jayaprakash Pagadala, Christopher C. Coss, James T. Dalton, Charles B. Duke
  • Publication number: 20240353312
    Abstract: Apparatus and systems disclosed herein are designed to be used to study various forces acting on an athletic field or an athletic surface caused by the interaction between a shoe and the turf or athletic surface during a simulated impact. Various surfaces can be tested and analyzed, including assessing deceleration, acceleration and cutting traction potential on the surfaces. The disclosed apparatuses and systems allow for the testing of a wide variety of footwear, at any desired impact angle, and at various simulated forces. Methods, systems, and computer readable media for generating graphical representations associated with surface performance test information are also disclosed herein.
    Type: Application
    Filed: August 23, 2022
    Publication date: October 24, 2024
    Applicant: University of Tennessee Research Foundation
    Inventors: Kyley Hampton Dickson, John Charles Sorochan
  • Publication number: 20240344145
    Abstract: The disclosure relates to methods for characterizing and/or treating a subject having cancer, said methods comprising performing an assay to identify the nucleotides present at each of a set of single-nucleotide polymorphism (SNP) locations within the cytarabine (ara-C) pathway, assigning a genotype score for the identified nucleotides of each SNP, and characterizing the subject having cancer based on the summation of the assigned genotype scores. In some embodiments, treatment is administered based upon the characterization of the subject, according to the methods described herein.
    Type: Application
    Filed: August 15, 2022
    Publication date: October 17, 2024
    Applicants: University of Florida Research Foundation, Incorporated, St. Jude Children's Research Hospital, Inc., University of Tennessee Research Foundation
    Inventors: Jatinder Kaur Lamba, Abdelrahman H. Elsayed, Xueyuan Cao, Stanley Pounds
  • Patent number: 12115146
    Abstract: This invention relates to the treatment of breast cancer in a subject, for example a female subject.
    Type: Grant
    Filed: October 9, 2020
    Date of Patent: October 15, 2024
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Mitchell S. Steiner, Ramesh Narayanan, Sunjoo Ahn, James T. Dalton
  • Publication number: 20240326697
    Abstract: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and processes for producing the same.
    Type: Application
    Filed: June 13, 2024
    Publication date: October 3, 2024
    Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: James T. DALTON, Thomas G. BIRD, Tai AHN, David A. DICKASON, Seoung-Soo HONG
  • Publication number: 20240325341
    Abstract: of treating Gram-negative bacteria that also exhibit resistance to the anti-bacterial compound colistin (MIC?50 mg/mL) except for Burkholderia, Proteus, and Serratia that comprises contacting the bacteria with an aqueous pharmaceutical composition containing a rose bengal (RB) compound of Formula I, below, dissolved or dispersed therein at a concentration of about 0.01 to about 15 mg/mL and irradiating those contacted bacteria with light of the wavelength about 500 nm to about 600 nm for a time period of about 1 to about 10 minutes to provide a light dose of about 16 to about 160 J/cm2, treat and kill the irradiated bacteria wherein X, R1, R2 and M+ are defined within.
    Type: Application
    Filed: March 25, 2024
    Publication date: October 3, 2024
    Applicants: Provectus Pharmatech, Inc., University of Tennessee Research Foundation
    Inventors: Michio KUROSU, Dominic Rodrigues, Edward V. Pershing, Bruce Horowitz, John Lacey, Eric A. Wachter
  • Publication number: 20240316043
    Abstract: The present disclosure related to compounds of Formula (I): stereoisomers thereof, prodrugs thereof, and pharmaceutically acceptable salts thereof. The present disclosure also relates to uses of the compounds, including to treat cancer in a subject.
    Type: Application
    Filed: March 21, 2024
    Publication date: September 26, 2024
    Applicant: University of Tennessee Research Foundation
    Inventors: Duane Miller, Lawrence Pfeffer, Yali He, Yinan Wang, Chuan Yang
  • Publication number: 20240294415
    Abstract: A method of additive manufacturing is described wherein powder material is spread in a layer, contacted with a binding polymer and cured with light. Also described is a system for preparing additive manufactured objects such as molds, tools and composites.
    Type: Application
    Filed: July 25, 2022
    Publication date: September 5, 2024
    Applicant: University of Tennessee Research Foundation
    Inventors: Dustin Blake Gilmer, Alexander Kendall Stiles
  • Publication number: 20240289950
    Abstract: A method and system for detection of retinal hemorrhages using head computed tomography incorporating deep learning includes obtaining a patient head computed tomography image, segmenting globes using a deep-learning model, rotating the scans using the angle between globes, cropping and masking the globes, and stacking the globes to form 3D individual images that are analyzed for presence of retinal hemorrhage.
    Type: Application
    Filed: January 24, 2024
    Publication date: August 29, 2024
    Applicant: University of Tennessee Research Foundation
    Inventors: Nadeem Shafi, Fatma Gunturkun, Berna Bakir Batu
  • Patent number: 12073161
    Abstract: A system includes a controller that is configured to generate a node control signal and a plurality of switch control signals, a plurality of programmable emulators, each of the plurality of programmable emulators being configurable as one of a plurality of node types responsive to the node control signal, and a plurality of switches that are programmable to couple ones of the plurality of programmable emulators to each other responsive to the plurality of switch control signals.
    Type: Grant
    Filed: April 19, 2021
    Date of Patent: August 27, 2024
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Fei Wang, Leon M. Tolbert, Yiwei Ma, Kevin Louis Tomsovic, Kai Sun, Shuoting Zhang, Jingxin Wang, Bo Liu
  • Patent number: 12057304
    Abstract: Machine learning approach can combine mass spectral imaging (MSI) techniques, one with low spatial resolution but intact molecular spectra and the other with nanometer spatial resolution but fragmented molecular signatures, to predict molecular MSI spectra with submicron spatial resolution. The machine learning approach can perform transformations on the spectral image data of the two MSI techniques to reduce dimensionality, and using a correlation technique, find relationships between the transformed spectral image data. The determined relationships can be used to generate MSI spectra of desired resolution.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: August 6, 2024
    Assignees: UT-Battelle, LLC, University of Tennessee Research Foundation
    Inventors: Olga S. Ovchinnikova, Anton V. Ievlev, Matthias Lorenz, Nikolay Borodinov, Steven T. King
  • Patent number: 12053448
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: August 6, 2024
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: James T. Dalton, Thomas G. Bird, Tai Ahn, David A. Dickason, Seoung-Soo Hong
  • Publication number: 20240252964
    Abstract: Filter media comprising cellulose fibers and fibrillated thermoplastic fibers, such as fibrillated polyolefins are described. The filter media can be provided in the form of non-woven fiber mats (e.g., wet-laid non-woven fiber mats) that can be integrated into air filtration devices to enhance their biodegradability. The non-woven fiber mats can be prepared as electrets. Composites comprising multiple layers of the same or different filter media can be prepared. Composites having minimum efficiency reporting value (MERV) ratings of at least 12 or at least 13 are described.
    Type: Application
    Filed: September 27, 2022
    Publication date: August 1, 2024
    Applicant: University of Tennessee Research Foundation
    Inventors: Uday Kumar Vasant Vaidya, Ganesh Deka
  • Publication number: 20240239930
    Abstract: Modified maleic acid copolymers have an esterified styrene maleic acid or diisobutylene maleic acid. The copolymers have 1% to 90% total esterification of the maleic acid (MA), thereby having an ester of Y1 and/or Y2 of the general formula —OR1. R1 is a moiety present in enough units of the copolymer in one or both of Y1 and Y2 to provide a preselected percent of total esterification, and if either or both of Y1 and Y2 are not esterified, it is a hydrogen or a carboxylate unit with a counterion X+. R1 comprises (i) a linear alkane chain, (ii) a linear chain alkoxy alkane of the formula —(CH2)qO(CH2)rCH3, (iii) an alkane containing or terminating with a cyclic carbon chain, (iv) an alkoxy alkane containing or terminating with a cyclic carbon chain, (v) a chain containing a repeating sequence of (CH2CH2O)t terminating with —OR2, or a mixture of (i) to (v).
    Type: Application
    Filed: May 6, 2022
    Publication date: July 18, 2024
    Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: Nathan G. BRADY, Cameron E. WORKMAN, Barry D. BRUCE, Brain K. LONG